446 related articles for article (PubMed ID: 38468489)
1. Unlocking the potential of T-cell metabolism reprogramming: Advancing single-cell approaches for precision immunotherapy in tumour immunity.
Huang L; Li H; Zhang C; Chen Q; Liu Z; Zhang J; Luo P; Wei T
Clin Transl Med; 2024 Mar; 14(3):e1620. PubMed ID: 38468489
[TBL] [Abstract][Full Text] [Related]
2. Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Yan L; Tan Y; Chen G; Fan J; Zhang J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638609
[TBL] [Abstract][Full Text] [Related]
3. Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity.
Zhang S; Zhang X; Yang H; Liang T; Bai X
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189022. PubMed ID: 37993001
[TBL] [Abstract][Full Text] [Related]
4. Advances in macrophage and T cell metabolic reprogramming and immunotherapy in the tumor microenvironment.
Cheng H; Zheng Y
PeerJ; 2024; 12():e16825. PubMed ID: 38239299
[TBL] [Abstract][Full Text] [Related]
5. Advances in reprogramming of energy metabolism in tumor T cells.
Xuekai L; Yan S; Jian C; Yifei S; Xinyue W; Wenyuan Z; Shuwen H; Xi Y
Front Immunol; 2024; 15():1347181. PubMed ID: 38415258
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.
Kishton RJ; Sukumar M; Restifo NP
Cell Metab; 2017 Jul; 26(1):94-109. PubMed ID: 28683298
[TBL] [Abstract][Full Text] [Related]
7. Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy.
Bahrambeigi S; Molaparast M; Sohrabi F; Seifi L; Faraji A; Fani S; Shafiei-Irannejad V
Immunol Lett; 2020 Apr; 220():32-37. PubMed ID: 31982460
[TBL] [Abstract][Full Text] [Related]
8. New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment.
Sung JY; Cheong JH
Cells; 2022 Feb; 11(5):. PubMed ID: 35269390
[TBL] [Abstract][Full Text] [Related]
9. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.
Li X; Wenes M; Romero P; Huang SC; Fendt SM; Ho PC
Nat Rev Clin Oncol; 2019 Jul; 16(7):425-441. PubMed ID: 30914826
[TBL] [Abstract][Full Text] [Related]
10. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
11. Metabolic interventions: A new insight into the cancer immunotherapy.
Yu T; Dong T; Eyvani H; Fang Y; Wang X; Zhang X; Lu X
Arch Biochem Biophys; 2021 Jan; 697():108659. PubMed ID: 33144083
[TBL] [Abstract][Full Text] [Related]
12. Metabolic adaptation of lymphocytes in immunity and disease.
Chapman NM; Chi H
Immunity; 2022 Jan; 55(1):14-30. PubMed ID: 35021054
[TBL] [Abstract][Full Text] [Related]
13. Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.
Kouidhi S; Ben Ayed F; Benammar Elgaaied A
Front Immunol; 2018; 9():353. PubMed ID: 29527212
[TBL] [Abstract][Full Text] [Related]
14. Reshaping immunometabolism in the tumour microenvironment to improve cancer immunotherapy.
Chen S; Duan H; Sun G
Biomed Pharmacother; 2023 Aug; 164():114963. PubMed ID: 37269814
[TBL] [Abstract][Full Text] [Related]
15. The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.
Li D; Cao D; Sun Y; Cui Y; Zhang Y; Jiang J; Cao X
Front Immunol; 2024; 15():1331641. PubMed ID: 38348027
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Regulation of CD8
Zheng Y; Wang X; Huang M
Antioxid Redox Signal; 2022 Dec; 37(16-18):1234-1253. PubMed ID: 35345890
[No Abstract] [Full Text] [Related]
17. Metabolic diversity of tumor-infiltrating T cells as target for anti-immune therapeutics.
Li P; Li F; Zhang Y; Yu X; Li J
Cancer Immunol Immunother; 2023 Nov; 72(11):3453-3460. PubMed ID: 37733059
[TBL] [Abstract][Full Text] [Related]
18. Immunometabolism: A new target for improving cancer immunotherapy.
Guo C; Chen S; Liu W; Ma Y; Li J; Fisher PB; Fang X; Wang XY
Adv Cancer Res; 2019; 143():195-253. PubMed ID: 31202359
[TBL] [Abstract][Full Text] [Related]
19. The Role of Tumor Metabolic Reprogramming in Tumor Immunity.
Zhang X; Song W; Gao Y; Zhang Y; Zhao Y; Hao S; Ni T
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139250
[TBL] [Abstract][Full Text] [Related]
20. Metabolic checkpoints and novel approaches for immunotherapy against cancer.
Li Y; Tang J; Jiang J; Chen Z
Int J Cancer; 2022 Jan; 150(2):195-207. PubMed ID: 34460110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
